lipid peg2000 dmg Search Results


90
Intellia Therapeutics lnps ionizable lipid, dspc, cholesterol, peg2000-dmg
Representative completed and ongoing clinical studies (immunotherapy)
Lnps Ionizable Lipid, Dspc, Cholesterol, Peg2000 Dmg, supplied by Intellia Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lnps ionizable lipid, dspc, cholesterol, peg2000-dmg/product/Intellia Therapeutics
Average 90 stars, based on 1 article reviews
lnps ionizable lipid, dspc, cholesterol, peg2000-dmg - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Walvax Biotechnology liposomes lipid 9001, cholesterol, dspc, dmg-peg2000
Representative completed and ongoing clinical studies (immunotherapy)
Liposomes Lipid 9001, Cholesterol, Dspc, Dmg Peg2000, supplied by Walvax Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liposomes lipid 9001, cholesterol, dspc, dmg-peg2000/product/Walvax Biotechnology
Average 90 stars, based on 1 article reviews
liposomes lipid 9001, cholesterol, dspc, dmg-peg2000 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Representative completed and ongoing clinical studies (immunotherapy)

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Representative completed and ongoing clinical studies (immunotherapy)

Article Snippet: Targeted genome engineering , Transthyretin amyloidosis (ATTR) with cardiomyopathy , NTLA-2001 , Cas9 protein , LNPs (ionizable lipid, DSPC, cholesterol, PEG2000-DMG) , Intravenous infusion , 2023-12-13 , Phase III , Recruiting , Intellia Therapeutics , NCT06128629.

Techniques: Virus, Injection, Membrane, Immunopeptidomics, Adjuvant, Activity Assay, Plasmid Preparation, Saline, Electroporation, Transfection, Inhibition

Representative completed and ongoing clinical studies (non-immunotherapy)

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Representative completed and ongoing clinical studies (non-immunotherapy)

Article Snippet: Targeted genome engineering , Transthyretin amyloidosis (ATTR) with cardiomyopathy , NTLA-2001 , Cas9 protein , LNPs (ionizable lipid, DSPC, cholesterol, PEG2000-DMG) , Intravenous infusion , 2023-12-13 , Phase III , Recruiting , Intellia Therapeutics , NCT06128629.

Techniques: Injection, CRISPR, Zinc-Fingers

Representative preclinical studies (non-immunotherapy)

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Representative preclinical studies (non-immunotherapy)

Article Snippet: Targeted genome engineering , Transthyretin amyloidosis (ATTR) with cardiomyopathy , NTLA-2001 , Cas9 protein , LNPs (ionizable lipid, DSPC, cholesterol, PEG2000-DMG) , Intravenous infusion , 2023-12-13 , Phase III , Recruiting , Intellia Therapeutics , NCT06128629.

Techniques: Coagulation, Injection, Polymer, Blocking Assay